Article
Emerging ethnic differences in lung cancer therapy
4 Nov 2008
Abstract excerpt
Although global clinical trials for lung cancer can enable the development of new agents efficiently, whether the results of clinical trials performed in one population can be fully extrapolated to another population remains questionable. A comparison of phase III trials for the same drug combinations against lung cancer in different countries shows a great diversity in haematological toxicity. One possible...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
